Tuesday, 02 January 2024 12:17 GMT

WHO Refutes Trump’s Assertion Linking Autism to Paracetamol


(MENAFN) The World Health Organization (WHO) firmly rejected US President Donald Trump’s recent assertion that paracetamol use during pregnancy is tied to autism, stating on Wednesday that no conclusive scientific evidence supports this claim.

In a detailed statement, the UN health agency highlighted that around 62 million people globally—or one in 127—live with autism spectrum disorder (ASD), a complex group of conditions impacting brain development. While diagnosis and awareness have improved, WHO emphasized that the exact causes of autism remain uncertain and likely involve multiple factors.

Trump’s Monday comment suggested that taking Tylenol, known internationally as paracetamol, during pregnancy could be linked to a “significantly increased risk of autism.”

However, the WHO underscored that “extensive research over the past decade, including large-scale studies, has not established a consistent association between paracetamol use in pregnancy and autism.” The agency further reiterated that a strong body of scientific evidence confirms that childhood vaccines do not cause autism, debunking earlier misconceptions about ingredients like thiomersal or aluminum.

WHO Director-General Tedros Adhanom Ghebreyesus advised on the US social media platform X that pregnant women should “follow medical advice regarding medications during pregnancy and exercise caution when taking any drug, particularly during the first trimester.”

MENAFN25092025000045017169ID1110109579

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search